Systematic review shows regional differences in HS comorbidity prevalence across North America, Europe, and Asia.
Regional differences in health risks for hidradenitis suppurativa patients
This systematic review and meta-analysis examines the prevalence of hidradenitis suppurativa-associated comorbidities across North America, …
A meta-analysis reveals how hidradenitis suppurativa patients in North America, Europe, and the Middle East/Asia face different odds for dia…
Narrative review discusses ginsenosides for skin conditions including psoriasis and dermatitis with noted evidence gaps.
Review of ginsenosides for skin conditions shows weak evidence and low absorption.
This narrative review examines the use of ginsenosides for various skin conditions, including psoriasis, dermatitis, photoaging, chronic non…
A review of ginsenosides for skin issues like psoriasis and melanoma found the evidence is insufficient and absorption is low.
Herring roe oil reduces inflammatory biomarkers in mild-to-moderate psoriasis
Herring roe oil may lower inflammation in psoriasis
In a randomized controlled trial post hoc analysis of 64 patients with mild-to-moderate psoriasis, oral herring roe oil supplementation for …
A small trial found that herring roe oil reduced several blood-based inflammation markers in people with mild-to-moderate psoriasis over 26 …
Secukinumab improves skin response in Chinese patients with psoriatic arthritis
Secukinumab linked to skin improvement in Chinese psoriatic arthritis patients
This observational cohort study of 446 Chinese patients with psoriatic arthritis found that treatment with secukinumab for over 12 weeks was…
In Chinese psoriatic arthritis patients, secukinumab treatment was associated with significant skin improvement and better quality of life o…
Autoimmune Thyroiditis Prevalence Higher in Obese Women With PCOS in Retrospective Cohort Analysis
New PCOS Data Reveals Hidden Thyroid Risks
This retrospective cohort study evaluated 1,249 women with PCOS aged 18–44 years. The prevalence of autoimmune thyroiditis was 20.3%, with a…
Women with PCOS should check their thyroid health regularly.
MONO, ORM1, ORM2, and AGP levels show excellent diagnostic value for psoriasis identification in a retrospective case-control study.
New Blood Test Could Spot Psoriasis Earlier, Study Suggests
This retrospective case-control study evaluated MONO, ORM1, ORM2, and AGP levels in 140 participants, including 70 patients with dermatology…
This research offers a new way to spot psoriasis risk early using a simple blood test, which could lead to faster treatment and better skin …
Review of cohort data finds AD linked to psoriasis risk and biologics associated with lower risk.
Atopic Dermatitis Raises Psoriasis Risk, But Biologics Help
This narrative review synthesizes findings from a large cohort study. It reports an association between atopic dermatitis and increased inci…
A massive study shows that while eczema increases the chance of getting psoriasis, modern biologic drugs significantly protect against this …
Higher composite dietary antioxidant index associated with lower all-cause mortality in psoriasis patients.
Higher dietary antioxidants linked to lower death risk in psoriasis patients
This prospective cohort study evaluated 500 individuals with psoriasis from the NHANES database. Participants were followed from 2003 to 201…
Psoriasis patients who eat more antioxidants face a lower risk of death, according to a study tracking 500 people over more than a decade.
CXCL13 quantification in PBMCs and plasma distinguishes Sézary syndrome from other cutaneous T-cell lymphomas and dermatoses.
A simple blood test could spot a rare skin cancer faster
This cohort study analyzed CXCL13 expression in peripheral blood mononuclear cells (PBMCs) and plasma concentrations in patients with suspec…
A simple blood test for a protein called CXCL13 may help doctors catch a rare, aggressive skin cancer that often looks like eczema for years…
Secukinumab improves cutaneous adipose tissue inflammatory signatures in psoriasis patients.
Fat Under Your Skin Fuels Psoriasis Inflammation
This randomized placebo-controlled trial evaluated secukinumab in 82 patients with psoriasis. The study assessed changes in the cutaneous ad…
Your body fat is not just storing energy; it is actively making your psoriasis worse, and new treatments are finally targeting this hidden f…
Bimekizumab maintains complete skin clearance in 73% of psoriasis patients at 4 years
Can psoriasis treatment keep skin clear for years? New data suggests it might.
A pooled analysis of phase 3 trials and open-label extension in 503 psoriasis patients found 73.0% of those achieving complete clearance at …
After four years on bimekizumab, about 73% of patients with psoriasis kept their skin completely clear, suggesting the treatment may help re…
Sliding Cupping Therapy Matches NBUVB in Psoriasis Severity Reduction at 8 Weeks
Could Sliding Cupping Therapy Be a Game-Changer for Psoriasis Patients?
In a RCT with 60 psoriasis patients, sliding cupping showed similar efficacy to NBUVB in reducing PASI scores by 62.4% vs. 66.9% (P=.526).
Sliding cupping therapy improved psoriasis symptoms just as well as standard light treatment, offering a viable alternative for patients see…